Aspects of early arthritis. Traditional DMARD therapy: is it sufficient? - Wikidata - wikimedia - TriplyDB

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

http://www.wikidata.org/entity/Q36486374

about

Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.Discovery of a highly selective JAK3 inhibitor for the treatment of rheumatoid arthritis.

P2860

Q46116182-7A40E208-1382-4C80-B6EA-29D64643E2E5 Q52626728-5B293445-5903-473F-AD49-E085BCFA5000

P2860

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

http://www.wikidata.org/entity/Q36486374

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

@ast

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

@en

type

label

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

@ast

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

@en

prefLabel

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

@ast

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

@en

P1433

Q36486374-D2ED69FF-CF67-4BCD-B008-616CB76A25F9

P1476

Q36486374-FD09FA34-F0D2-4392-A519-57303176CA07

P2093

Q36486374-434D8D6D-C8B8-4D6C-AA6C-828055C6CD7C

Q36486374-BB566ADC-E394-4C36-8E99-0C2CEB25AD7D

Q36486374-BC46E34B-B930-49EF-AA69-4061DCCA90CE

P2860

Q36486374-06561BB7-6BE7-4884-8F91-F064E28567B9

Q36486374-1546095A-BF3A-473B-B88E-DC18BBA125C6

Q36486374-19CA8935-0581-4FD4-93B9-14FAE804BE3E

Q36486374-1DFCBB4E-A8DE-4DB6-B041-BA72F099C660

Q36486374-1E8FD8BF-F719-450B-874E-32504EA5F91B

Q36486374-209D392F-46F2-4105-9D6D-825F3164E3A7

Q36486374-2339ADA9-654F-4F22-B02B-F4B220C5E9FB

Q36486374-28B95A23-A1A7-4C91-A1ED-226C67130E17

Q36486374-4B84C311-20B7-4FC6-9119-7633C4BBDE40

Q36486374-53C5D0ED-DBE9-4258-B32C-5CE97D3E4A57

P2888

Q36486374-0C65D534-7A64-4BD8-A0EE-923200DBB885

P304

Q36486374-5E2B2013-43D0-41FC-9EF8-B5E23FCBA226

P31

Q36486374-4E49DD3D-C760-440C-B567-AFC51EEF076F

Q36486374-5F7B20DB-891B-4456-A043-1B1C3B75739C

P356

Q36486374-A5EDF357-4332-4085-8B6B-E2B3DF08628E

P433

Q36486374-1ED8E934-9C4E-4C38-8D8F-43BB0B2713B4

P478

Q36486374-F6A1D58A-578C-488C-95A8-6C321193BE8C

P50

Q36486374-CE33D35B-4506-4A81-9570-35A191265838

P577

Q36486374-CAE8F0EB-9F94-4A66-A45D-3B864631B6F3

P5875

Q36486374-7F4FE996-3627-4F17-A6B8-6004A3036DAD

P6179

Q36486374-47994C79-0D7F-488E-9019-E47B281B9698

P698

Q36486374-2694CA7B-2977-4FE0-88E2-0618A473CFC2

P921

Q36486374-221E0A62-DED2-491F-9939-D5D481065C7F

P932

Q36486374-499ED40D-CD82-4216-850B-953B704A5C9A

P356

P1433

Arthritis Research and Therapy

P1476

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

@en

P2093

Klaus P Machold

http://www.w3.org/2001/XMLSchema#string

Tanja A Stamm

http://www.w3.org/2001/XMLSchema#string

Valerie P K Nell

http://www.w3.org/2001/XMLSchema#string

P2860

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

Mortality in rheumatoid arthritis.

Early inflammatory polyarthritis: results from the norfolk arthritis register with a review of the literature. I. Risk factors for the development of inflammatory polyarthritis and rheumatoid arthritis.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

P2888

P304

211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR1966

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7062594

http://www.w3.org/2001/XMLSchema#string

P6179

1041198605

http://www.w3.org/2001/XMLSchema#string

P698

16719936

http://www.w3.org/2001/XMLSchema#string

P921

rheumatoid arthritis

P932

1526637

http://www.w3.org/2001/XMLSchema#string